Stevens-Johnson Syndrome as an unusual adverse effect of azithromycin

Acta Dermatovenerologica Croatica

Volumn 14, Issue 1, 2006, Pages 40-45

  Brkljačić, Neva ^a   Gracin, Sonja ^a   Prkačin, Ingrid ^a   Sabljar Matovinović, Mirjana ^a   Mrzljak, Anna ^a   Nemet, Zlatka ^b  

^a University of Zagreb   (Croatia)

^b General Hospital   (Croatia)

Author keywords

Azithromycin; Stevens johnson syndrome

Indexed keywords

AZITHROMYCIN; METHYLPREDNISOLONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHILL; CLINICAL FEATURE; COLLAGEN DISEASE; DERMATITIS; DRUG EFFECT; ERYTHEMA; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INFLAMMATORY DISEASE; MACULOPAPULAR RASH; MEDICAL EXAMINATION; RHEUMATIC DISEASE; STEVENS JOHNSON SYNDROME; UPPER RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; FEMALE; HUMANS; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; STEVENS-JOHNSON SYNDROME;

EID: 33646053492     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Stevens AM, Johnson FC. New eruptive fever associated with stomatitis and ophthalmia. Am J Dis Child 1922;24:526-33.
2. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 1956;68:355-61.
3. Chan H, Stern RS, Arnat KA, Langlois J, Jick SS, Jick H, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol 1990;126:43-7.
4. Bastuji-Gari S, Rzany B, Stern RS, Sheer NH, Naldi L, Roujean JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-6.
5. Guillaume JC, Roujeau JC, Revuz J, Penso D, Touraine R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 1987;123:1166-70.
6. Howland WW, Golitz LE, Weston WL, Huff JC. Erythema multiforme: clinical, histopathologic and immunologic study. J Am Acad Dermatol 1984;10:438-46.
7. Ledesma GN, McCormack PC. Erythema multiforme. Clin Dermatol 1986;4:70-80.
8. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
9. Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol 1991;127:839-42.
10. Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Shaw M, et al. A population based study of Stevens Johnson syndrome: incidence and antecedent drug exposures. Arch Dermatol 1991;127:831-8.
11. Ting HC, Adam BA. Stevens-Johnson syndrome. Int J Dermatol 1985;24:587-91.
12. Wright P, Collin JR. The ocular complications of erythema multiforme (Stevens-Johnson syndrome) and their management. Trans Ophthal Soc UK 1983;103:338-41.
13. Mondino BJ, Brown SI, Biglan AW. HLA antigens in Stevens-Johnson syndrome with ocular involvement. Arch Ophthalmol 1982;100:1453-4.
14. Sheretz EF, Reed JN, Zanolli MD, Goldsmith SM. Severe allergic keratoconjunctivitis and erythema multiforme after a routine eye examination: discerning the cause. Ann Ophthalmol 1991;23:173-6.
15. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Flechet ML, Girre JP. Toxic epidermal necrolysis (Lyell syndrome): incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990;126:37-42.
16. Garty BZ. Stevens-Johnson syndrome associated with nystatin treatment. Arch Dermatol 1991;127:741-2.
17. Levy M, Shear NH. Mycoplasma pneumoniae infections and Stevens-Johnson syndrome: report of eight cases and review of the literature. Clin Pediatr 1991;30:42-9.
18. Witkowski JA, Parish LC. Cutaneous reaction to antibacterial agents. Skinmed 2002;1:33-44.
19. Aihara Y, Ito S, Kobayashi Y, Aihara M. Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herplex simplex virus infection. Allergy 2004;59:118.
20. McDonald K, Johnson B, Prasad JK, Thomson PD. Rehabilitative considerations for patients with severe Stevens-Johnson syndrome or toxic epidermal necrolysis. J Burn Care Rehabil 1989;10:167-71.
21. Nethercott JR, Choi BC. Erythema multiforme (Stevens-Johnson syndrome) chart review of 123 hospitalized patients. Dermatologica 1985;171:383-96.
22. Patterson R, Dykewicz MS, Gonzalzles A, Grammer LC, Green D, Greenberger PA, et al. Erythema multiforme and Stevens-Johnson syndrome: descriptive and therapeutic controversy. Chest 1990;98:331-6.
23. Bossi P, Roujeau JC, Bricaire F, Caumes E. Stevens-Johnson syndrome associated with abacavir therapy. Clin Infect Dis 2002;1:35:902.
24. Pagot JP, Mockenhaupt M, Bouwes-Bavnic JN, Naldi L, Viboud C, Roujeau JC. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001;15:1843-8.
25. Porteous DM, Berger TG. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection. Arch Dermatol 1991;127:740-1.
26. Renfro L, GrantKells JM, Feder HM Jr, Daman LA. Controversy: are systemic steroids indicated in the treatment of erythema multiforme. Pediatr Dermatol 1989;6:43-50.
27. Prendiville JS, Hebert AA, Greenwald MJ, Esterly NB. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr 1989;115:881-7.
28. Williams DA. Stevens-Johnson syndrome after erythromycin therapy while deployed at sea. Mil Med 2000;165:636-7.
29. Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000;136:323-7.